123 related articles for article (PubMed ID: 3159898)
1. Neurochemical approaches to the pathogenesis of Down's syndrome.
Balazs R; Brooksbank BW
J Ment Defic Res; 1985 Mar; 29 ( Pt 1)():1-14. PubMed ID: 3159898
[No Abstract] [Full Text] [Related]
2. Superoxide dismutase and lipoperoxidation in Down's syndrome fetal brain.
Brooksbank BW; Balázs R
Lancet; 1983 Apr; 1(8329):881-2. PubMed ID: 6132215
[No Abstract] [Full Text] [Related]
3. Down's syndrome, dementia, and superoxide dismutase.
Prasher VP; Chung MC
Br J Psychiatry; 1993 Oct; 163():552. PubMed ID: 8252302
[No Abstract] [Full Text] [Related]
4. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain.
Brooksbank BW; Balazs R
Brain Res; 1984 Sep; 318(1):37-44. PubMed ID: 6237715
[TBL] [Abstract][Full Text] [Related]
5. Cell damage by excess CuZnSOD and Down's syndrome.
Groner Y; Elroy-Stein O; Avraham KB; Schickler M; Knobler H; Minc-Golomb D; Bar-Peled O; Yarom R; Rotshenker S
Biomed Pharmacother; 1994; 48(5-6):231-40. PubMed ID: 7999984
[TBL] [Abstract][Full Text] [Related]
6. Is the mental deterioration in Down's syndrome linked to impaired terminal degradation of neurofilaments?
Elomaa E; Virtanen I
Med Hypotheses; 1985 Feb; 16(2):171-2. PubMed ID: 3157856
[TBL] [Abstract][Full Text] [Related]
7. Lipid peroxides in blood plasma and enzymatic antioxidative defence of erythrocytes in Down's syndrome.
Kedziora J; Bartosz G; Gromadzińska J; Skłodowska M; Wesowicz W; Scianowski J
Clin Chim Acta; 1986 Feb; 154(3):191-4. PubMed ID: 2937579
[TBL] [Abstract][Full Text] [Related]
8. [Dosage effect of the cytoplasmic superoxide dismutase (SOD-1) gene in the erythrocytes of Down's syndrome patients].
Tamarkina AD; Annenkov GA; Filippov IK; Lamchingiĭn T
Genetika; 1977; 13(5):929-32. PubMed ID: 147797
[TBL] [Abstract][Full Text] [Related]
9. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.
Ceballos-Picot I; Nicole A; Briand P; Grimber G; Delacourte A; Defossez A; Javoy-Agid F; Lafon M; Blouin JL; Sinet PM
Brain Res; 1991 Jun; 552(2):198-214. PubMed ID: 1717112
[TBL] [Abstract][Full Text] [Related]
10. Moderate Down's syndrome in three siblings having partial trisomy 21q22.2 to qter and therefore no SOD-1 excess.
Habedank M; Rodewald A
Hum Genet; 1982; 60(1):74-7. PubMed ID: 6210617
[No Abstract] [Full Text] [Related]
11. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the human CuZnSOD gene in transfected cells--implication to Down syndrome.
Elroy-Stein O; Bernstein Y; Avraham KB; Dafni N; Levanon D; Danciger E; Neer A; Groner Y
Prog Clin Biol Res; 1987; 253():373-92. PubMed ID: 2963346
[No Abstract] [Full Text] [Related]
13. Increased superoxide dismutase and Down's syndrome.
Turrens JF
Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
[TBL] [Abstract][Full Text] [Related]
14. Lipid peroxides in the free radical pathophysiology of brain diseases.
Farooqui AA; Horrocks LA
Cell Mol Neurobiol; 1998 Dec; 18(6):599-608. PubMed ID: 9876868
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of Down's syndrome: overexpression of transfected human Cu/Zn-superoxide dismutase gene and the consequent physiological changes.
Groner Y; Elroy-Stein O; Bernstein Y; Dafni N; Levanon D; Danciger E; Neer A
Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 1():381-93. PubMed ID: 2953545
[No Abstract] [Full Text] [Related]
16. Down's syndrome, dementia, and superoxide dismutase.
Dickinson MJ; Singh I
Br J Psychiatry; 1993 Jun; 162():811-7. PubMed ID: 8392422
[No Abstract] [Full Text] [Related]
17. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome.
Gulesserian T; Seidl R; Hardmeier R; Cairns N; Lubec G
J Investig Med; 2001 Jan; 49(1):41-6. PubMed ID: 11217146
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of oxygen derivatives in down's syndrome.
Sinet PM
Ann N Y Acad Sci; 1982; 396():83-94. PubMed ID: 6217779
[No Abstract] [Full Text] [Related]
19. Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice.
Avraham KB; Sugarman H; Rotshenker S; Groner Y
J Neurocytol; 1991 Mar; 20(3):208-15. PubMed ID: 1828079
[TBL] [Abstract][Full Text] [Related]
20. [Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging].
Ceballos-Picot I
C R Seances Soc Biol Fil; 1993; 187(3):308-23. PubMed ID: 8019910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
